Navigation Links
Mindray Medical to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Date:8/19/2009

SHENZHEN, China, Aug. 19 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that Mindray management will present on Monday, September 14 at 9:10 am EDT at the Morgan Stanley Global Healthcare Unplugged Conference in New York, NY. The conference will be held at the Grand Hyatt.

The conference will be attended by Mr. Ronald Ede, Mindray's chief financial officer, Ms. May Li, Mindray's director of investor relations and Ms. Winnie Liang, Mindray's manager of investor relations. Mr. Ronald Ede will be presenting on behalf of Mindray.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .

    For investor and media inquiries, please contact:

    In the U.S.:

    Evan Smith, CFA
     FD
     Tel:   +1-212-850-5606
     Email: evan.smith@fd.com

    John Capodanno
     FD
     Tel:   +1-212-850-5705
     Email: john.capodanno@fd.com

    In China:

    Cathy Gao
     Tel:   +86-755-2658-2518
     Email: cathy.gao@mindray.com

'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mindray Announces Second Quarter 2009 Financial Results
2. Mindray Medical Provides Mid-Year Update on Product Development and GPO Contracts
3. Mindray to Report Second Quarter 2009 Financial Results on August 10, 2009
4. Mindray to Attend the 2009 American Association for Clinical Chemistry Conference
5. Mindray Announces First Quarter 2009 Financial Results
6. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
7. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
8. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
9. Mindray Announces Option Exchange Offer
10. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
11. Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear warfare has ... a company involved in the underground testing of nuclear weapons. Years later, when her ... Workers of the Cold War Nuclear Testing,” Clayton exposes the critical decisions made by ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – ... disclosed that despite scientific studies, the Center for Disease Control ( CDC ) and ... . Kenneth B. Liegner, M.D. has compiled into a single volume a compelling ...
(Date:2/27/2017)... ... 2017 , ... New Jersey ranks among the top five states in the ... need for advanced services is growing. , Project WE vs C is a ... with their non-profit partners in their fight against cancer and in support of their ...
(Date:2/26/2017)... ... February 26, 2017 , ... LatitudeC Baby Products, an ... announced it would be offering some it’s exclusive product line to the public ... and unique baby clothing/feeding products, will team up with AMAZON to distribute a ...
(Date:2/26/2017)... Florida (PRWEB) , ... February 26, 2017 , ... ... of Parkinson’s disease (PD) in persons with a specific LRRK2 mutation, according to ... Congress. , Previous studies have provided evidence of a link between pesticides and ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 23, 2017  Directors from Pharma To Market Pty Ltd ... joined forces, resulting in the founding of Pharma To Market Pte ... To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... the Singapore based entity. Joelle brings with ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... , Feb 24, 2017 ... Committee,s proposal for a new Board of Directors that ... The 2016-2017 Nomination Committee comprises representatives of the company,s ... quarter of 2016 who have accepted a seat on ... The composition of the 2016-2017 Nomination Committee was as ...
Breaking Medicine Technology: